How likely is deal? Bloomberg reported that AstraZeneca contacted Gilead last month about a potential $232 bln pharma powerhouse merger. According to Jefferie analysts the merger is unlikely
<p> A Cypriot financial firm offering wealth management services has landed in hot water after suspicious transactions worth hundreds of millions. TCR International Limited, an investment adviso
Leave a Comment